These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 28612750)

  • 21. Alcohol-Related Liver Disease: Basic Mechanisms and Clinical Perspectives.
    Liu SY; Tsai IT; Hsu YC
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34068269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of microRNAs in alcohol-induced liver disorders and non-alcoholic fatty liver disease.
    Torres JL; Novo-Veleiro I; Manzanedo L; Alvela-Suárez L; Macías R; Laso FJ; Marcos M
    World J Gastroenterol; 2018 Sep; 24(36):4104-4118. PubMed ID: 30271077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alcohol, microbiome, life style influence alcohol and non-alcoholic organ damage.
    Neuman MG; French SW; Zakhari S; Malnick S; Seitz HK; Cohen LB; Salaspuro M; Voinea-Griffin A; Barasch A; Kirpich IA; Thomes PG; Schrum LW; Donohue TM; Kharbanda KK; Cruz M; Opris M
    Exp Mol Pathol; 2017 Feb; 102(1):162-180. PubMed ID: 28077318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alcoholic Liver Disease: Role of Cytokines.
    Neuman MG; Maor Y; Nanau RM; Melzer E; Mell H; Opris M; Cohen L; Malnick S
    Biomolecules; 2015 Aug; 5(3):2023-34. PubMed ID: 26343741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unraveling the Complex Interplay between Epigenetics and Immunity in Alcohol-Associated Liver Disease: A Comprehensive
    Liu Y; Liu T; Zhang F; Gao Y
    Int J Biol Sci; 2023; 19(15):4811-4830. PubMed ID: 37781509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New advances in molecular mechanisms and emerging therapeutic targets in alcoholic liver diseases.
    Williams JA; Manley S; Ding WX
    World J Gastroenterol; 2014 Sep; 20(36):12908-33. PubMed ID: 25278688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetics of alcoholic liver disease and nonalcoholic fatty liver disease.
    Wilfred de Alwis NM; Day CP
    Semin Liver Dis; 2007 Feb; 27(1):44-54. PubMed ID: 17295176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oxidative mechanisms in the pathogenesis of alcoholic liver disease.
    Albano E
    Mol Aspects Med; 2008; 29(1-2):9-16. PubMed ID: 18045675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inflammation in alcoholic liver disease.
    Wang HJ; Gao B; Zakhari S; Nagy LE
    Annu Rev Nutr; 2012 Aug; 32():343-68. PubMed ID: 22524187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alcoholic liver disease: pathogenesis and new therapeutic targets.
    Gao B; Bataller R
    Gastroenterology; 2011 Nov; 141(5):1572-85. PubMed ID: 21920463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytokines in alcoholic liver disease.
    An L; Wang X; Cederbaum AI
    Arch Toxicol; 2012 Sep; 86(9):1337-48. PubMed ID: 22367091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune dysregulation and pathophysiology of alcohol consumption and alcoholic liver disease.
    Martinez-Castillo M; Altamirano-Mendoza I; Sánchez-Valle S; García-Islas L; Sánchez-Barragán M; Hernández-Santillán M; Hernández-Barragán A; Pérez-Hernández JL; Higuera-de la Tijera F; Gutierrez-Reyes G
    Rev Gastroenterol Mex (Engl Ed); 2023; 88(2):136-154. PubMed ID: 36973122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxidative stress and redox signaling mechanisms of alcoholic liver disease: updated experimental and clinical evidence.
    Zhu H; Jia Z; Misra H; Li YR
    J Dig Dis; 2012 Mar; 13(3):133-142. PubMed ID: 22356308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential epigenetic mechanism in non-alcoholic Fatty liver disease.
    Sun C; Fan JG; Qiao L
    Int J Mol Sci; 2015 Mar; 16(3):5161-79. PubMed ID: 25751727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alcohol and the mechanisms of liver disease.
    Chen M; Zhong W; Xu W
    J Gastroenterol Hepatol; 2023 Aug; 38(8):1233-1240. PubMed ID: 37423758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Redox homeostasis and epigenetics in non-alcoholic fatty liver disease (NAFLD).
    Podrini C; Borghesan M; Greco A; Pazienza V; Mazzoccoli G; Vinciguerra M
    Curr Pharm Des; 2013; 19(15):2737-46. PubMed ID: 23092327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alcohol-Associated Liver Disease Outcomes: Critical Mechanisms of Liver Injury Progression.
    Osna NA; Tikhanovich I; Ortega-Ribera M; Mueller S; Zheng C; Mueller J; Li S; Sakane S; Weber RCG; Kim HY; Lee W; Ganguly S; Kimura Y; Liu X; Dhar D; Diggle K; Brenner DA; Kisseleva T; Attal N; McKillop IH; Chokshi S; Mahato R; Rasineni K; Szabo G; Kharbanda KK
    Biomolecules; 2024 Mar; 14(4):. PubMed ID: 38672422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathogenesis, Early Diagnosis, and Therapeutic Management of Alcoholic Liver Disease.
    Kong LZ; Chandimali N; Han YH; Lee DH; Kim JS; Kim SU; Kim TD; Jeong DK; Sun HN; Lee DS; Kwon T
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31159489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Roles of the complement system in alcohol-induced liver disease.
    Zhou Y; Yuan G; Zhong F; He S
    Clin Mol Hepatol; 2020 Oct; 26(4):677-685. PubMed ID: 33053939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology.
    Loria P; Marchesini G; Nascimbeni F; Ballestri S; Maurantonio M; Carubbi F; Ratziu V; Lonardo A
    Atherosclerosis; 2014 Jan; 232(1):99-109. PubMed ID: 24401223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.